As of 2026-04-02, the Relative Valuation of CureVac NV (CVAC) is 5.38 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.66 USD, the upside of CureVac NV based on Relative Valuation is 15.5%.
The range of the Relative Valuation is 1.93 - 9.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 14.6x | 13.3x |
| Forward P/E multiples | 17.9x - 19.3x | 18.6x |
| Fair Price | 1.93 - 9.62 | 5.38 |
| Upside | -58.7% - 106.3% | 15.5% |
| Date | P/E |
| 2026-01-05 | 7.08 |
| 2026-01-02 | 7.09 |